Cn1cnc(C(=O)NCc2ccc(CNC(=O)OC(C)(C)C)cc2)c1C(=O)NCc1ccc(CNC(=O)OC(C)(C)C)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?